Suppr超能文献

相似文献

1
The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.
Cell Host Microbe. 2007 Apr 19;1(2):135-45. doi: 10.1016/j.chom.2007.03.002.
2
The molecular basis of antibody-mediated neutralization of West Nile virus.
Expert Opin Biol Ther. 2007 Jun;7(6):885-92. doi: 10.1517/14712598.7.6.885.
3
The structural immunology of antibody protection against West Nile virus.
Immunol Rev. 2008 Oct;225:212-25. doi: 10.1111/j.1600-065X.2008.00676.x.
4
Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization.
PLoS Pathog. 2008 May 9;4(5):e1000060. doi: 10.1371/journal.ppat.1000060.
5
Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection.
mBio. 2021 Oct 26;12(5):e0244021. doi: 10.1128/mBio.02440-21. Epub 2021 Oct 12.
6
The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states.
J Virol. 2013 Dec;87(24):13729-40. doi: 10.1128/JVI.02340-13. Epub 2013 Oct 9.
7
A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus.
PLoS Pathog. 2011 Jun;7(6):e1002111. doi: 10.1371/journal.ppat.1002111. Epub 2011 Jun 30.
8
A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
Vaccine. 2018 Mar 27;36(14):1846-1852. doi: 10.1016/j.vaccine.2018.02.073. Epub 2018 Feb 26.
9
A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection.
Virology. 2006 Mar 1;346(1):53-65. doi: 10.1016/j.virol.2005.10.030. Epub 2005 Dec 2.
10
Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.
J Virol. 2009 Jul;83(13):6494-507. doi: 10.1128/JVI.00286-09. Epub 2009 Apr 22.

引用本文的文献

1
Preexisting yellow fever virus and West Nile virus immunity and pregnancy outcomes in a Nigerian cohort with endemic orthoflavivirus exposure.
Emerg Microbes Infect. 2025 Dec;14(1):2544720. doi: 10.1080/22221751.2025.2544720. Epub 2025 Aug 21.
6
7
Enhanced Assessment of Cross-Reactive Antigenic Determinants within the Spike Protein.
Int J Mol Sci. 2024 Jul 26;25(15):8180. doi: 10.3390/ijms25158180.
8
Mechanisms of antibody-dependent enhancement of infectious disease.
Nat Rev Immunol. 2025 Jan;25(1):6-21. doi: 10.1038/s41577-024-01067-9. Epub 2024 Aug 9.

本文引用的文献

2
Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.
J Virol. 2006 Dec;80(24):12149-59. doi: 10.1128/JVI.01732-06. Epub 2006 Oct 11.
4
Crystal structure of the West Nile virus envelope glycoprotein.
J Virol. 2006 Dec;80(23):11467-74. doi: 10.1128/JVI.01125-06. Epub 2006 Sep 20.
5
Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites.
J Virol. 2006 Oct;80(19):9557-68. doi: 10.1128/JVI.00080-06.
6
Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.
J Virol. 2006 Nov;80(22):11000-8. doi: 10.1128/JVI.01735-06. Epub 2006 Aug 30.
7
West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody.
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12400-4. doi: 10.1073/pnas.0603488103. Epub 2006 Aug 8.
8
West Nile virus activity in Latin America and the Caribbean.
Rev Panam Salud Publica. 2006 Feb;19(2):112-7. doi: 10.1590/s1020-49892006000200006.
9
Introductions of West Nile virus strains to Mexico.
Emerg Infect Dis. 2006 Feb;12(2):314-8. doi: 10.3201/eid1202.050871.
10
West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection.
J Virol. 2006 Feb;80(3):1290-301. doi: 10.1128/JVI.80.3.1290-1301.2006.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验